Madrigal is eying an expansion of MASH blockbuster Rezdiffra’s capabilities via combination with precision siRNA gene ...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year ended December 31, 2025 and ...
Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...
Mucormycosis is a rapidly progressive, invasive fungal infection that affects patients who are severely immunocompromised, as well as patients with diabetes and persons with immunocompetence who have ...
Amgen added to uncertainty surrounding the OX40 drug class by returning an autoimmune candidate to Kyowa Kirin. | Amgen added ...
Detailed price information for Wave Life Sci Ord Sh (WVE-Q) from The Globe and Mail including charting and trades.
Senior Labour members of parliament (MPs) are calling on U.K. Prime Minister Keir Starmer to ban cryptocurrency donations to political parties, warning these could be used by hostile foreign actors to ...
When making a Dungeons and Dragons character, few decisions are as important as the class. Furthermore, players must consider what level the campaign is reaching, as any given class is going to ...
President Donald Trump is asking the office of Fulton County District Attorney Fani Willis to reimburse him more than $6.2 million in attorney fees and costs in the wake of the recently dismissed 2020 ...
Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...
Leading RNA drug developer Suzhou Ribo Life Science Co. Ltd. passed its hearing for a listing on the Hong Kong Stock Exchange, marking the official launch of its IPO, according to its post-hearing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results